Insider Trades44 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 400,000 | $19.88 | $4.3B | -17.85% | +223.25% | $8.0M | +0.00% | — | Sell Now |
| May 4, 2026 | Sell | EWTX | Joanne M. Donovan | CMO | 105,230 | $23.24 | $4.3B | -17.85% | +223.25% | $2.4M | -3.65% | — | Sell Now |
| Apr 1, 2026 | Sell | EWTX | Joanne M. Donovan | CMO | 57,324 | $19.70 | $4.3B | -17.85% | +223.25% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Mar 31, 2026 | Sell | EWTX | Joanne M. Donovan | CMO | 42,676 | $19.60 | $4.3B | -17.85% | +223.25% | $836.4K | +0.00% | 10b5-1 | Sell Now |
| Mar 27, 2026 | Sell | EWTX | Joanne M. Donovan | CMO | 16,358 | $30.98 | $4.3B | -17.85% | +223.25% | $506.7K | -38.68% | — | Sell Now |
| Nov 12, 2025 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 200,000 | $10.65 | $4.3B | -17.85% | +223.25% | $2.1M | +0.00% | — | Sell Now |
| Aug 26, 2025 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 200,000 | $7.39 | $4.3B | -17.85% | +223.25% | $1.5M | +0.00% | — | Sell Now |
| Aug 12, 2025 | Sell | EWTX | R Michael Carruthers | Chief Financial Officer | 1,428 | $13.39 | $4.3B | -17.85% | +223.25% | $19.1K | -0.49% | — | Sell Now |
| Aug 12, 2025 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 1,907 | $13.39 | $4.3B | -17.85% | +223.25% | $25.5K | -0.80% | — | Sell Now |
| Aug 12, 2025 | Sell | EWTX | John R Moore | General Counsel | 2,098 | $13.39 | $4.3B | -17.85% | +223.25% | $28.1K | -0.96% | — | Sell Now |
| Aug 12, 2025 | Sell | EWTX | Behrad Derakhshan | Chief Business Officer | 2,491 | $13.39 | $4.3B | -17.85% | +223.25% | $33.4K | -0.98% | — | Sell Now |
| Aug 12, 2025 | Sell | EWTX | Joanne M. Donovan | CMO | 2,862 | $13.39 | $4.3B | -17.85% | +223.25% | $38.3K | -1.18% | — | Sell Now |
| Aug 12, 2025 | Sell | EWTX | Kevin Koch | President and CEO | 7,972 | $13.39 | $4.3B | -17.85% | +223.25% | $106.8K | -1.13% | — | Sell Now |
| May 2, 2025 | Sell | EWTX | R Michael Carruthers | Chief Financial Officer | 1,314 | $16.45 | $4.3B | -17.85% | +223.25% | $21.6K | -1.60% | — | Sell Now |
| May 2, 2025 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 1,551 | $16.45 | $4.3B | -17.85% | +223.25% | $25.5K | -7.73% | — | Sell Now |
| May 2, 2025 | Sell | EWTX | Behrad Derakhshan | Chief Business Officer | 1,691 | $16.45 | $4.3B | -17.85% | +223.25% | $27.8K | -7.67% | — | Sell Now |
| May 2, 2025 | Sell | EWTX | John R Moore | General Counsel | 1,930 | $16.45 | $4.3B | -17.85% | +223.25% | $31.8K | -22.81% | — | Sell Now |
| May 2, 2025 | Sell | EWTX | Kevin Koch | President and CEO | 4,276 | $16.45 | $4.3B | -17.85% | +223.25% | $70.4K | -17.18% | — | Sell Now |
| May 2, 2025 | Sell | EWTX | Joanne M. Donovan | CMO | 5,187 | $16.45 | $4.3B | -17.85% | +223.25% | $85.3K | -19.37% | — | Sell Now |
| Mar 7, 2025 | Sell | EWTX | Kevin Koch | President and CEO | 200 | $15.09 | $4.3B | -17.85% | +223.25% | $3.0K | +0.00% | 10b5-1 | Sell Now |
| Mar 7, 2025 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 400 | $15.10 | $4.3B | -17.85% | +223.25% | $6.0K | +0.00% | 10b5-1 | Sell Now |
| Feb 5, 2025 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 18,430 | $15.11 | $4.3B | -17.85% | +223.25% | $278.4K | +0.00% | 10b5-1 | Sell Now |
| Feb 5, 2025 | Sell | EWTX | Kevin Koch | President and CEO | 19,072 | $15.76 | $4.3B | -17.85% | +223.25% | $300.7K | +0.00% | 10b5-1 | Sell Now |
| Feb 5, 2025 | Sell | EWTX | Behrad Derakhshan | Chief Business Officer | 20,000 | $15.98 | $4.3B | -17.85% | +223.25% | $319.6K | +0.00% | 10b5-1 | Sell Now |
| Jan 28, 2025 | Sell | EWTX | Joanne M. Donovan | CMO | 50,000 | $17.35 | $4.3B | -17.85% | +223.25% | $867.7K | +0.00% | 10b5-1 | Sell Now |
| Dec 30, 2024 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 200,000 | $13.78 | $4.3B | -17.85% | +223.25% | $2.8M | +0.00% | 10b5-1 | Sell Now |
| Dec 24, 2024 | Sell | EWTX | Marc Semigran | Chief Development Officer | 59,418 | $19.31 | $4.3B | -17.85% | +223.25% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Oct 11, 2024 | Buy | EWTX | R Michael Carruthers | Chief Financial Officer | 70,000 | $0.71 | $4.3B | -17.85% | +223.25% | $49.7K | +52.23% | — | Sell Now |
| Sep 20, 2024 | Sell | EWTX | Joanne M. Donovan | CMO | 7,162 | $28.29 | $4.3B | -17.85% | +223.25% | $202.6K | -33.00% | — | Sell Now |
| Sep 20, 2024 | Sell | EWTX | Behrad Derakhshan | Chief Business Officer | 84,136 | $15.48 | $4.3B | -17.85% | +223.25% | $1.3M | +0.00% | — | Sell Now |
| Sep 20, 2024 | Sell | EWTX | John R Moore | General Counsel | 141,844 | $14.43 | $4.3B | -17.85% | +223.25% | $2.0M | +0.00% | — | Sell Now |
| Sep 20, 2024 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 150,000 | $14.22 | $4.3B | -17.85% | +223.25% | $2.1M | +0.00% | — | Sell Now |
| Sep 20, 2024 | Sell | EWTX | R Michael Carruthers | Chief Financial Officer | 221,160 | $17.00 | $4.3B | -17.85% | +223.25% | $3.8M | -9.99% | — | Sell Now |
| May 2, 2024 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 1,576 | $18.91 | $4.3B | -17.85% | +223.25% | $29.8K | -11.24% | — | Sell Now |
| May 2, 2024 | Sell | EWTX | Behrad Derakhshan | Chief Business Officer | 1,718 | $18.91 | $4.3B | -17.85% | +223.25% | $32.5K | -8.44% | — | Sell Now |
| May 2, 2024 | Sell | EWTX | John R Moore | General Counsel | 1,956 | $18.91 | $4.3B | -17.85% | +223.25% | $37.0K | -18.78% | — | Sell Now |
| May 2, 2024 | Sell | EWTX | R Michael Carruthers | Chief Financial Officer | 2,157 | $18.91 | $4.3B | -17.85% | +223.25% | $40.8K | -5.06% | — | Sell Now |
| May 2, 2024 | Sell | EWTX | Kevin Koch | President and CEO | 3,152 | $18.91 | $4.3B | -17.85% | +223.25% | $59.6K | -11.24% | — | Sell Now |
| May 2, 2024 | Sell | EWTX | Joanne M. Donovan | CMO | 3,682 | $18.91 | $4.3B | -17.85% | +223.25% | $69.6K | -10.83% | — | Sell Now |
| Feb 7, 2024 | Sell | EWTX | Behrad Derakhshan | Chief Business Officer | 20,000 | $10.98 | $4.3B | -17.85% | +223.25% | $219.6K | +0.00% | 10b5-1 | Sell Now |
| Feb 7, 2024 | Sell | EWTX | John R Moore | General Counsel | 59,670 | $10.97 | $4.3B | -17.85% | +223.25% | $654.4K | +0.00% | 10b5-1 | Sell Now |
| Jan 23, 2024 | Sell | EWTX | R Michael Carruthers | Chief Financial Officer | 180,000 | $8.85 | $4.3B | -17.85% | +223.25% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Dec 27, 2023 | Sell | EWTX | John R Moore | General Counsel | 8,497 | $10.50 | $4.3B | -17.85% | +223.25% | $89.2K | -100.00% | 10b5-1 | Sell Now |
| Dec 26, 2023 | Sell | EWTX | Alan J Russell | Chief Scientific Officer | 172,585 | $9.33 | $4.3B | -17.85% | +223.25% | $1.6M | -97.95% | — | Sell Now |